Investigation of DNA-damage and Chromosomal Aberrations in Blood Cells under the Influence of New Silver-based Antiviral Complex; Advanced Pharmaceutical Bulletin (APB); Vol. 6, iss. 1

Detaylı Bibliyografya
Parent link:Advanced Pharmaceutical Bulletin (APB)
Vol. 6, iss. 1.— 2016.— [P. 71-74]
Müşterek Yazar: Национальный исследовательский Томский политехнический университет Институт природных ресурсов Кафедра физической и аналитической химии
Diğer Yazarlar: Plotnikov E. V. Evgeny Vladimirovich, Silnikov V. A. Vladimir A ., Gapeev A. B. Andrey Bronislavovich, Plotnikov V. M.
Özet:Title screen
Purpose: The problem of infectious diseases and drug resistance is becoming increasingly important worldwide. Silver is extensively used as an anti-infective agent, but it has significant toxic side effects. In this regard, it is topical to develop new silver compounds with high biological activity and low toxicity. This work is aimed to study DNA damage and chromosomal aberrations in blood cells under the influence of new silver-based compound of general formula C6H19Ag2N4LiO6S2, with antiviral activity. Methods: The comet assay was applied for the genotoxic affects assessment on mice blood leukocytes. DNA damage was determined bases on the percentage of DNA in a comet tail (tail DNA), under the influence of silver complex in different concentrations. Genotoxic effect of the tested substance on the somatic cells was determined by chromosomal aberration test of bone marrow cells of mice. Results: In the course of the experiments, no essential changes in the level of DNA damage in the cells were found, even at highest concentrations. The administration of the substance in doses up to 2.5 g/kg in mice did not cause any increase in the frequency of chromosomal aberration in bone marrow cells. Conclusion: Taking into account known silver drug genotoxic properties, the use of a given complexed silver compound has possible great advantages for potential applications in the treatment of infectious diseases.
Dil:İngilizce
Baskı/Yayın Bilgisi: 2016
Konular:
Online Erişim:http://dx.doi.org/10.15171/apb.2016.011
Materyal Türü: Elektronik Kitap Bölümü
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=649100

MARC

LEADER 00000naa0a2200000 4500
001 649100
005 20250228114712.0
035 |a (RuTPU)RU\TPU\network\14261 
090 |a 649100 
100 |a 20160620d2016 k||y0rusy50 ba 
101 0 |a eng 
102 |a IR 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a Investigation of DNA-damage and Chromosomal Aberrations in Blood Cells under the Influence of New Silver-based Antiviral Complex  |f E. V. Plotnikov [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 16 tit.] 
330 |a Purpose: The problem of infectious diseases and drug resistance is becoming increasingly important worldwide. Silver is extensively used as an anti-infective agent, but it has significant toxic side effects. In this regard, it is topical to develop new silver compounds with high biological activity and low toxicity. This work is aimed to study DNA damage and chromosomal aberrations in blood cells under the influence of new silver-based compound of general formula C6H19Ag2N4LiO6S2, with antiviral activity. Methods: The comet assay was applied for the genotoxic affects assessment on mice blood leukocytes. DNA damage was determined bases on the percentage of DNA in a comet tail (tail DNA), under the influence of silver complex in different concentrations. Genotoxic effect of the tested substance on the somatic cells was determined by chromosomal aberration test of bone marrow cells of mice. Results: In the course of the experiments, no essential changes in the level of DNA damage in the cells were found, even at highest concentrations. The administration of the substance in doses up to 2.5 g/kg in mice did not cause any increase in the frequency of chromosomal aberration in bone marrow cells. Conclusion: Taking into account known silver drug genotoxic properties, the use of a given complexed silver compound has possible great advantages for potential applications in the treatment of infectious diseases. 
461 |t Advanced Pharmaceutical Bulletin (APB) 
463 |t Vol. 6, iss. 1  |v [P. 71-74]  |d 2016 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a генотоксичность 
610 1 |a противовирусные препараты 
610 1 |a хромосомные аберрации 
701 1 |a Plotnikov  |b E. V.  |c chemist  |c Associate Professor of Tomsk Polytechnic University, Candidate of Chemical Sciences  |f 1983-  |g Evgeny Vladimirovich  |3 (RuTPU)RU\TPU\pers\32469  |9 16417 
701 1 |a Silnikov  |b V. A.  |g Vladimir A . 
701 1 |a Gapeev  |b A. B.  |g Andrey Bronislavovich 
701 1 |a Plotnikov  |b V. M. 
712 0 2 |a Национальный исследовательский Томский политехнический университет  |b Институт природных ресурсов  |b Кафедра физической и аналитической химии  |3 (RuTPU)RU\TPU\col\18656  |9 27109 
801 2 |a RU  |b 63413507  |c 20160620  |g RCR 
856 4 |u http://dx.doi.org/10.15171/apb.2016.011 
942 |c CF